Peer-reviewedCC BY-NC-ND 4.0Annals of Translational Medicine
Hydroxyurea and transfusion together: a step forward in defining the value of combination therapy in severe sickle cell disease
- 1Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN, USA
Related
- Sickle Cell Disease Care in Jamaica: Enablers and Barriers to Healthcare Access and Hydroxyurea Utilization
- A liquid- and capsule-compatible hydroxyurea electronic monitor to identify non-adherent youth with sickle cell disease
- Hydroxyurea treatment is not significantly associated with reduced spermatogonial numbers in patients with sickle cell disease
- Long-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms.
- Dyadic Coping with Dyspnoea-Related Kinesiophobia in Couples Living with COPD: "Entrapped Together or Moving Through Together" - A Constructivist Grounded Theory.
BibTeX
@article{rai2026hydroxyurea,
title = {{Hydroxyurea and transfusion together: a step forward in defining the value of combination therapy in severe sickle cell disease}},
author = {Parul Rai and Sandra Capellera-Garcia and Deepa Manwani},
journal = {Annals of Translational Medicine},
year = {2026},
month = oct,
doi = {10.21037/atm-2026-0069},
url = {https://doi.org/10.21037/atm-2026-0069},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Hydroxyurea and transfusion together: a step forward in defining the value of combination therapy in severe sickle cell disease
AU - Parul Rai
AU - Sandra Capellera-Garcia
AU - Deepa Manwani
PY - 2026
DA - 2026/10/08
JO - Annals of Translational Medicine
DO - 10.21037/atm-2026-0069
UR - https://doi.org/10.21037/atm-2026-0069
SN - 2305-5839
SN - 2305-5847
ER -